Rezolute, Inc.
General ticker "RZLT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $524.7M (TTM average)
Rezolute, Inc. does not follow the US Stock Market performance with the rate: -5.3%.
Estimated limits based on current volatility of 6.9%: low 3.87$, high 4.44$
Factors to consider:
- Total employees count: 71 (+20.3%) as of 2025
- Top business risk factors: Regulatory and compliance, Clinical trial delays, Capital raising failure, Manufacturing capacity, Intellectual property risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [2.67$, 6.93$]
- 2027-06-30 to 2028-06-29 estimated range: [2.83$, 7.16$]
Short-term RZLT quotes
Long-term RZLT plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $70.42MM | $79.89MM | $82.97MM |
| Operating Income | $-70.42MM | $-79.89MM | $-82.97MM |
| Non-Operating Income | $1.96MM | $5.48MM | $5.38MM |
| R&D Expense | $55.74MM | $61.53MM | $53.80MM |
| Income(Loss) | $-68.46MM | $-74.41MM | $-77.59MM |
| Net Income(Loss)* | $-68.46MM | $-74.41MM | $-77.59MM |
| Stockholders Equity | $121.00MM | $162.13MM | $100.69MM |
| Assets | $132.74MM | $175.49MM | $112.85MM |
| Operating Cash Flow | $-57.37MM | $-69.08MM | $-64.64MM |
| Investing Cash Flow | $48.70MM | $-14.54MM | $-21.10MM |
| Financing Cash Flow | $63.03MM | $107.33MM | $2.24MM |
| Earnings Per Share** | $-1.33 | $-0.98 | $-0.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.